|
|
|
| The evaluation on clinical effect of Chaishao Liujun Decoction in the treatment of chronic kidney disease stage 3-4 |
Department of Nephrology, Wenzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medicine University, Wenzhou, 325000
|
|
| Cite this article: |
|
SUN Yun,DONG Feixia,CHENG Jinguo.. The evaluation on clinical effect of Chaishao Liujun Decoction in the treatment of chronic kidney disease stage 3-4[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2015, 45(3): 208-.
|
|
|
Abstract Objective: To evaluate the clinical effect of Chaishao Liujun Decoction therapy in treating Chronic Kidney Disease (CKD) stage 3 to 4, which is based on tonifying kidney and spleen, elevating Yang and defusing Qi. Methods: Seventy-two qualified cases were collected from CKD stage outpatients or hospitalized patients of Wenzhou hospital of traditional Chinese medicine, and the cases were divided randomly into two groups and each group was composed of 36 cases. On the basis of routine treatment, the patients in treatment group were treated with Chaishao Liujun Decoction. The treatment period was 3 months. The changes of clinical symptoms,
renal function and hemoglobin level of both groups were observed. Results: There wasn’t statistical significant difference between two groups in clinical syndromes of Traditional Chinese Medicine (TCM) and renal function level before treatment. After a treatment period, the clinical symptoms of TCM in both groups could be improved and the efficacy in the treatment group was much better, the comparison had a statistical significance (P<0.05). The efficacy of improving renal function and hemoglobin level in the treatment group was better than that of the control group’s, the comparison had a statistical significance (P<0.05). The clinical therapeutic effect in the treatment group was better than that of the control group, the comparison had a statistical significance (P<0.01); Both two groups were no adverse reaction. Conclusion: The Chaishao Liujun Decoction can improve clinical symptoms, renal function and hemoglobin of patients with CKD stage 3 to 4, and delay the progression of CKD.
|
|
Received: 28 September 2014
|
| |
|
|
|
|
|
|
